Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vera Bradley, Inc. - Common Stock (NQ: VRA )

3.815 +0.095 (+2.55%)
Streaming Delayed Price Updated: 2:43 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vera Bradley, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block
TD Bank is considering a Charles Schwab stake sale while Disney inks deal with FuboTV. Meanwhile, bankruptcy cases spiked in 2024. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Deal Dispatch: Vera Bradley Is A Mixed Bag, Modell's Ex-CEO Explores Party City
Vera Bradley faces shareholder pressure for underperformance, while acquisitions and restructurings define this week's deal landscape. 
Via Benzinga
Assessing Vera Bradley: Insights From 5 Financial Analysts
Via Benzinga
Vera Bradley Reports 30% Sales Drop In Q3 Amid Business Model Transition, Stock Slips
Vera Bradley's Q3 sales drop 30%, and the company lowers its FY25 revenue forecast, causing shares to fall. 
Via Benzinga
Recap: Vera Bradley Q3 Earnings
Via Benzinga
Examining the Future: Vera Bradley's Earnings Outlook
Via Benzinga
Expert Outlook: Vera Bradley Through The Eyes Of 5 Analysts
Via Benzinga
Assessing Vera Bradley: Insights From 6 Financial Analysts
Via Benzinga
Earnings Scheduled For December 11, 2024
Via Benzinga
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
Via Benzinga
The Latest Analyst Ratings For Vera Bradley
Via Benzinga
Vera Bradley Hurt By Stubborn Macro Headwinds In Q2, Stock Plummets
Vera Bradley's Q2 earnings and revenues miss estimates, hurt by persistent macro headwinds, leading to a sharp drop in shares and a lowered FY25 outlook. 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Vera Bradley
Via Benzinga
In-Depth Examination Of 7 Analyst Recommendations For Vera Bradley
Via Benzinga
The Analyst Verdict: Vera Bradley In The Eyes Of 6 Experts
Via Benzinga
VRA Stock Earnings: Vera Bradley Misses Revenue for Q1 2025
VRA stock results show that Vera Bradley missed on revenue for the first quarter of 2025. 
Via InvestorPlace
S&P 500 Tops 5,400 As Federal Reserve Holds Rates Steady, Inflation Eases
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Crude Oil Moves Higher; Vera Bradley Shares Slide
Via Benzinga
Exposures Fossil Fuels
Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
SHARE Series Live at NYSE
Hear from High Growth Small-Cap Presenters 
Via News Direct
Deep Dive Into Vera Bradley Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
4 Analysts Have This To Say About Vera Bradley
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
Via Benzinga
Why Fashion Retailer Vera Bradley's Shares Are Plunging Today
Vera Bradley experienced a decline in shares after reporting a significant 14.6% drop in first-quarter FY25 sales to $80.6 million, falling short of expectations by nearly $10 million. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Vera Bradley's July Reset To Focus On Core Categories, Says Analyst
Vera Bradley receives a bullish nod from Small Cap Consumer Research, affirming a Buy rating with a $10.00 price target. Analysts highlight the surge in demand for mini handbags, noting the popularity... 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Vera Bradley Shares Are Falling Today
Vera Bradley reports Q4 earnings miss, with revenues of $133.3M, down from estimates, highlighting challenging macroeconomic environment and Project Restoration rollout in FY25. 
Via Benzinga
Topics Earnings
Exposures Financial
Earnings Scheduled For March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.